IMA Clinical Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Depression2 trials
• Type 2 diabetes2 trials
• Alzheimer disease1 trial
• Chronic kidney disease1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Completed4 trials
• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company4 trials
• Denovo Biopharma LLC1 trial
• Sirtsei Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  NCT06254612· Phase 2· Sirtsei Pharmaceuticals, Inc.· Source

• Completed

  A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT05872620· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Completed

  A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

  NCT05113771· Phase 2· Denovo Biopharma LLC· Source